A carregar...
Tau Immunotherapy and Imaging
Disappointing findings from recent Phase III trials on amyloid-β (Aβ) immunotherapy for Alzheimer’s disease (AD) have shifted the focus of such treatments to the tau protein. As tau pathology correlates better with the degree of dementia than Aβ plaque burden, it is a more attractive target once cog...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946316/ https://ncbi.nlm.nih.gov/pubmed/24029727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000354491 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|